Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Arrowhead Pharmaceuticals (ARWR)
NASDAQ:ARWR
Arrowhead Pharmaceuticals (ARWR) Stock Price & Analysis
1,183 Followers
ARWR Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$23.09 - $48.48
Previous Close$34.41
Volume1.03M
Average Volume (3M)1.17M
Market Cap
$3.50B
Enterprise Value$3.12B
Total Cash (Recent Filing)$481.00M
Total Debt (Recent Filing)$82.78M
Price to Earnings (P/E)-24.1
Beta1.27
Next Earnings
Aug 03, 2023EPS Estimate
-$0.61Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.43
Shares Outstanding106,900,421
10 Day Avg. Volume938,628
30 Day Avg. Volume1,171,768
Standard Deviation0.22
R-Squared0.06
Alpha0.04
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)25.15
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue11.45
Enterprise Value/Gross Profit12.85
Enterprise Value/Ebitda-32.52
Forecast
1Y Price Target
$56.89Price Target Upside64.09% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering10
Arrowhead Pharmaceuticals News
Pre-EarningsARWR Earnings this Week: How Will it Perform?
Market NewsArrowhead Soars after New Asthma Drug Tests
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ARWR FAQ
What was Arrowhead Pharmaceuticals’s price range in the past 12 months?
Arrowhead Pharmaceuticals lowest stock price was $23.09 and its highest was $48.48 in the past 12 months.
What is Arrowhead Pharmaceuticals’s market cap?
Currently, no data Available
When is Arrowhead Pharmaceuticals’s upcoming earnings report date?
Arrowhead Pharmaceuticals’s upcoming earnings report date is Aug 03, 2023 which is in 62 days.
How were Arrowhead Pharmaceuticals’s earnings last quarter?
Arrowhead Pharmaceuticals released its earnings results on May 02, 2023. The company reported $0.45 earnings per share for the quarter, beating the consensus estimate of -$0.618 by $1.068.
Is Arrowhead Pharmaceuticals overvalued?
According to Wall Street analysts Arrowhead Pharmaceuticals’s price is currently Undervalued.
Does Arrowhead Pharmaceuticals pay dividends?
Arrowhead Pharmaceuticals does not currently pay dividends.
What is Arrowhead Pharmaceuticals’s EPS estimate?
Arrowhead Pharmaceuticals’s EPS estimate is -$0.61.
How many shares outstanding does Arrowhead Pharmaceuticals have?
Arrowhead Pharmaceuticals has 106,900,420 shares outstanding.
What happened to Arrowhead Pharmaceuticals’s price movement after its last earnings report?
Arrowhead Pharmaceuticals reported an EPS of $0.45 in its last earnings report, beating expectations of -$0.618. Following the earnings report the stock price went up 13.624%.
Which hedge fund is a major shareholder of Arrowhead Pharmaceuticals?
Among the largest hedge funds holding Arrowhead Pharmaceuticals’s share is Woodline Partners LP. It holds Arrowhead Pharmaceuticals’s shares valued at 15M.
---
Arrowhead Pharmaceuticals Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$56.89 (64.09% Upside)
$56.89 (64.09% Upside)
Blogger Sentiment
Bullish
ARWR Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 663.8K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $4.8M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▲ 2.1%
Last 30 Days ▲ 0.4%
Last 30 Days ▲ 0.4%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
3.14%
12-Months-Change
Fundamentals
Return on Equity
-33.41%
Trailing 12-Months
Asset Growth
26.68%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals, Inc. operates as a biopharmaceutical company. It develops medicines that treat intractable diseases by silencing the genes that cause them. The company was founded by R. Bruce Stewart in 1989 and is headquartered in Pasadena, CA.
---
Top 5 ETFs holding ARWR
Vanguard Total Stock Market ETF
$113.93M
Vanguard Health Care ETF
$12.48M
iShares Core S&P Total U.S. Stock Market ETF
$4.07M
Schwab U.S. Broad Market ETF
$2.00M
Fidelity MSCI Health Care Index ETF
$1.82M
Up to five ETFs with an Outperform Smart Score that hold ARWR. The ETFs are listed according to market value of ARWR within the ETF
---
---